Title |
Cabozantinib Unlocks Efficient In Vivo Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate Tumors
|
---|---|
Published in |
Molecular Cancer Therapeutics, February 2021
|
DOI | 10.1158/1535-7163.mct-20-0167 |
Pubmed ID | |
Authors |
Kiranj Kishor Chaudagar, Natalie Landon-Brace, Aniruddh Solanki, Hanna M Hieromnimon, Emma Hegermiller, Wen Li, Yue Shao, John Joseph, Devan J Wilkins, Kaela M Bynoe, Xiang-Ling Li, John G Clohessy, Soumya Ullas, Jeffrey M Karp, Akash Patnaik |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 57% |
Unknown | 3 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 57% |
Scientists | 2 | 29% |
Science communicators (journalists, bloggers, editors) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 22 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 4 | 18% |
Professor > Associate Professor | 3 | 14% |
Student > Ph. D. Student | 3 | 14% |
Student > Doctoral Student | 1 | 5% |
Lecturer | 1 | 5% |
Other | 4 | 18% |
Unknown | 6 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 4 | 18% |
Engineering | 3 | 14% |
Agricultural and Biological Sciences | 2 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Nursing and Health Professions | 1 | 5% |
Other | 2 | 9% |
Unknown | 9 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2021.
All research outputs
#6,219,324
of 23,267,128 outputs
Outputs from Molecular Cancer Therapeutics
#1,384
of 3,897 outputs
Outputs of similar age
#153,698
of 505,643 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#24
of 71 outputs
Altmetric has tracked 23,267,128 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 3,897 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 505,643 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.